News & Events » Media Stories
August 29, 2012- Eyewire Today | TV
Wednesday, 24 October 2012
|
Allergan, Inc., enters into two agreements with Molecular Partners AG to develop and commercialize a class of biological drugs for the treatment of ophthalmic diseases. Read More >
|









![Casting A Wide Net[work] | Presenting the interactive Foundation Fighting Blindness 2012 Annual Report 2012 Annual Report banner](https://www.blindness.org/images/banners/annual_report_box.jpg)


